It was notable that CaMK II upregulation plays a pivotal role in the pathogenesis of cardiovascular diseases (70), it was observed that long-term administration of canagliflozin significantly reduced ischemia/reperfusion injury on myocardial tissue in diabetic and non-diabetic rats, which was probably caused by a decline in CaMK II (71). Here, CAMK2G is linked to cardiovascular disorder.